These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34300163)

  • 1. Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants.
    Pope ZC; Kottke TJ; Shah A; Vile RG; Rizza SA
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on common surfaces by disinfectants.
    Pope ZC; Weisend CM; Shah A; Ebihara H; Rizza SA
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):504-506. PubMed ID: 35078553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
    Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
    Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes.
    Cutts TA; Robertson C; Theriault SS; Nims RW; Kasloff SB; Rubino JR; Ijaz MK
    Front Public Health; 2020; 8():183. PubMed ID: 32582604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and inactivation of vesicular stomatitis virus, a prototype rhabdovirus.
    Zimmer B; Summermatter K; Zimmer G
    Vet Microbiol; 2013 Feb; 162(1):78-84. PubMed ID: 22995872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential Oil Disinfectant Efficacy Against SARS-CoV-2 Microbial Surrogates.
    Bailey ES; Curcic M; Biros J; Erdogmuş H; Bac N; Sacco A
    Front Public Health; 2021; 9():783832. PubMed ID: 34970529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2.
    Franke G; Knobling B; Brill FH; Becker B; Klupp EM; Belmar Campos C; Pfefferle S; Lütgehetmann M; Knobloch JK
    J Hosp Infect; 2021 Jun; 112():108-113. PubMed ID: 33864891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus.
    Cutts TA; Kasloff SB; Krishnan J; Nims RW; Theriault SS; Rubino JR; Ijaz MK
    Front Public Health; 2021; 9():657443. PubMed ID: 34447735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of surface disinfection methods to inactivate the beta coronavirus Murine Hepatitis Virus.
    Hardison RL; Nelson SW; Barriga D; Feliciano Ruiz N; Ghere JM; Fenton GA; Lindstrom DJ; James RR; Stewart MJ; Lee SD; Calfee MW; Ryan SP; Howard MW
    J Occup Environ Hyg; 2022 Aug; 19(8):455-468. PubMed ID: 35687041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.
    Case JB; Rothlauf PW; Chen RE; Liu Z; Zhao H; Kim AS; Bloyet LM; Zeng Q; Tahan S; Droit L; Ilagan MXG; Tartell MA; Amarasinghe G; Henderson JP; Miersch S; Ustav M; Sidhu S; Virgin HW; Wang D; Ding S; Corti D; Theel ES; Fremont DH; Diamond MS; Whelan SPJ
    Cell Host Microbe; 2020 Sep; 28(3):475-485.e5. PubMed ID: 32735849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus.
    Alkayyal AA; Ajina R; Cacciabue M; Alkayyal AA; Saeedi NH; Hussain Alshehry T; Kaboha F; Alotaibi MA; Zaidan N; Shah K; Alroqi F; Bakur Mahmoud A
    Front Immunol; 2023; 14():1082191. PubMed ID: 36798114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
    Kapadia SU; Simon ID; Rose JK
    Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
    Li H; Zhao C; Zhang Y; Yuan F; Zhang Q; Shi X; Zhang L; Qin C; Zheng A
    Emerg Microbes Infect; 2020 Dec; 9(1):2269-2277. PubMed ID: 32990161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
    Havranek KE; Jimenez AR; Acciani MD; Lay Mendoza MF; Reyes Ballista JM; Diaz DA; Brindley MA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33353101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
    Espeseth AS; Yuan M; Citron M; Reiserova L; Morrow G; Wilson A; Horton M; Rukhman M; Kinek K; Hou F; Li SL; Li F; Choi Y; Heidecker G; Luo B; Wu G; Zhang L; Strable E; DeStefano J; Secore S; Mukhopadhyay TK; Richardson DD; Sayeed E; Welch LS; Bett AJ; Feinberg MB; Gupta SB; Cooper CL; Parks CL
    EBioMedicine; 2022 Aug; 82():104203. PubMed ID: 35915046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
    Fukushi S; Watanabe R; Taguchi F
    Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with dry hydrogen peroxide accelerates the decay of severe acute syndrome coronavirus-2 on non-porous hard surfaces.
    Huang YS; Bilyeu AN; Hsu WW; Hettenbach SM; Willix JL; Stewart SC; Higgs S; Vanlandingham DL
    Am J Infect Control; 2021 Oct; 49(10):1252-1255. PubMed ID: 34273464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
    Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
    Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
    Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
    J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.